TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

3 Cutting-Edge Biotech Stocks That Can Double in Value
MERGERS AND ACQUISITIONS

Why 2018 will be better for biotech deals than 2017

  • By Armie Margaret Lee
  • Jan 25, 2018 7:15 PM EST
PRESS RELEASES

Fate Therapeutics Announces Changes To Its Board Of Directors

  • By GlobeNewswire
  • May 5, 2020 4:01 PM EDT
PRESS RELEASES

Fate Therapeutics To Webcast Conference Call Reporting First Quarter 2020 Financial Results

  • By GlobeNewswire
  • May 4, 2020 4:01 PM EDT
PRESS RELEASES

Fate Therapeutics Announces Preclinical Data Presentation Of Novel CAR MICA/B Cell-based Cancer Immunotherapy Program At The 2020 ASGCT Annual Meeting

  • By GlobeNewswire
  • Apr 28, 2020 4:30 PM EDT
3 Cutting-Edge Biotech Stocks That Can Double in Value
MERGERS AND ACQUISITIONS

Why 2018 will be better for biotech deals than 2017

  • By Armie Margaret Lee
  • Jan 25, 2018 7:15 PM EST
Celgene Makes $9 Billion Cancer Treatment Play for Juno Therapeutics
OPINION

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

  • By Michael Brown
  • Jan 22, 2018 7:23 PM EST
Immunotherapy Stocks Power Higher on Celgene-Juno Deal
STOCKS

Immunotherapy stocks power higher on Celgene-Juno deal

  • By Armie Margaret Lee
  • Jan 22, 2018 12:03 PM EST
Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition
MERGERS AND ACQUISITIONS

More Immunotherapy Buyouts Likely After Kite Sale

  • By Armie Margaret Lee
  • Sep 2, 2017 10:20 AM EDT
Veeva Systems: Cramer's Top Takeaways
STOCKS

Biotech Movers: Fate Shares Spike After Cancer Studies Progress

  • By William McConnell
  • Aug 15, 2017 9:43 AM EDT
Why Apple Has Lost Its Once Huge Lead in Renting and Selling Movies
OPINION

5 stocks poised for big breakouts

  • By Roberto Pedone
  • Mar 4, 2016 7:14 AM EST
Jim Cramer -- To Analyze Sirius, Watch Car Sales
OPINION

8 stocks under $10 making big moves higher

  • By Roberto Pedone
  • Feb 26, 2016 8:16 AM EST
Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'
INVESTING

Four Stem-Cell Stocks With Promise

  • By Gregg Greenberg
  • Jul 30, 2015 2:19 PM EDT
Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst
VIDEO

Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst

  • By Gregg Greenberg
  • Jul 30, 2015 12:37 PM EDT
13 Best Small- and Mid-Cap Stocks to Buy for 2016
INVESTING

5 Stocks Under $10 Set to Soar Higher

  • By Roberto Pedone
  • May 7, 2015 11:06 AM EDT
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Oct 20, 2014 4:32 PM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

3 Drugs Stocks Nudging The Industry Higher

  • By TheStreet Wire
  • Oct 6, 2014 6:50 PM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

3 Stocks Boosting The Drugs Industry Higher

  • By TheStreet Wire
  • Sep 4, 2014 4:32 PM EDT
Top Insider Trades: AYR IVH PTGI REED
STOCKS

Top Insider Trades: CCXI AYR FATE CFIS

  • By Jonathan Moreland
  • Oct 8, 2013 9:44 AM EDT
BioTech IPOs With Big Partners
VIDEO

BioTech IPOs With Big Partners

  • By Debra Borchardt
  • Sep 18, 2013 3:00 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.